{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:01:06Z","timestamp":1793412066638,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Alzheimer\u2019s disease (AD) is the most common type of dementia. Genetic polymorphisms are associated with altered risks of AD onset, pointing to biological processes and potential targets for interventions. Consistent with the important roles of microglia in AD development, genetic mutations of several genes expressed on microglia have been identified as risks for AD. Emerging evidences indicate that the expression of a microglia-specific gene\n                      <jats:italic>MS4A6A<\/jats:italic>\n                      is thought to be associated with AD, since AD patients show upregulation of\n                      <jats:italic>MS4A6A<\/jats:italic>\n                      , and its levels correlate with the severity of clinical neuropathology. However, the mechanism linking MS4A6A and AD has not been experimentally studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a meta genome-wide association analysis with 734,121 subjects to examine the associations between polymorphisms of\n                      <jats:italic>MS4A6A<\/jats:italic>\n                      with AD risks. In addition, we analyzed the correlation between MS4A6A and AD-related cerebrospinal fluid biomarkers from our own cohort. Furthermore, we for the first time generated a Ms4a6d deficient APP\/PS1 model, and systematically examined pathological changes using high-resolution microscopy, biochemistry, and behavioral analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified several new mutations of\n                      <jats:italic>MS4A6A<\/jats:italic>\n                      with altered AD risks, and discovered specific correlation for some of them with the amount of \u03b2-amyloid in cerebrospinal fluid. Protective variant of\n                      <jats:italic>MS4A6A<\/jats:italic>\n                      is associated with elevated expression of the gene. Deficient Ms4a6d led to reduced amyloid clearance in the brain. Immunostaining from postmortem AD patients brain revealed selective expression of MS4A6A in microglia. In APP\/PS1 mice lacking Ms4a6d, microglia showed markedly diminished envelopment and phagocytosis of amyloid, leading to increased plaque burden, less compact structure, and more severe synaptic damage. Importantly, Ms4a6d deficiency markedly exacerbated inflammatory responses in both microglia and astrocytes by disinhibiting NF-\u03baB signaling. Overexpressing MS4A6A in human microglia cell line promoted gene expression related to plaque-associated responses and diminished inflammation signatures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings reveal that Ms4a6d deficiency suppresses neuroprotection and worsens neuroinflammation. Sufficient Ms4a6d maybe beneficial for boosting amyloid-related responses and suppressing inflammation in microglia, making it superior than previously reported candidates for microglia modulation. Thus, the elevated MS4A6A levels in AD are likely compensatory and boosting MS4A6A could be an effective treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-025-00887-0","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:42:12Z","timestamp":1756399332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["MS4A6A\/Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer\u2019s disease model"],"prefix":"10.1186","volume":"20","author":[{"given":"Hai-Shan","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piao-Piao","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ning","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-0547","authenticated-orcid":false,"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"887_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"887_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in Early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512\u201327.","journal-title":"JAMA"},{"key":"887_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci. 2020;23:311\u201322.","journal-title":"Nat Neurosci"},{"key":"887_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F. Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol. 2022;18:643\u201360.","journal-title":"Nat Rev Neurol"},{"key":"887_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"887_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330.","journal-title":"Nat Genet"},{"key":"887_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43:429\u201335.","journal-title":"Nat Genet"},{"key":"887_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jalz.2012.08.007","volume":"9","author":"L Tan","year":"2013","unstructured":"Tan L, Yu J-T, Zhang W, Wu Z-C, Zhang Q, Liu Q-Y, et al. Association of GWAS-linked loci with late-onset Alzheimer\u2019s disease in a northern Han Chinese population. Alzheimers Dement J Alzheimers Assoc. 2013;9:546\u201353.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"887_CR9","doi-asserted-by":"publisher","first-page":"58779","DOI":"10.18632\/oncotarget.9563","volume":"7","author":"J Ma","year":"2016","unstructured":"Ma J, Zhang W, Tan L, Wang H-F, Wan Y, Sun F-R, et al. MS4A6A genotypes are associated with the atrophy rates of Alzheimer\u2019s disease related brain structures. Oncotarget. 2016;7:58779.","journal-title":"Oncotarget"},{"key":"887_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neurobiolaging.2015.10.037","volume":"39","author":"LM Ramirez","year":"2016","unstructured":"Ramirez LM, Goukasian N, Porat S, Hwang KS, Eastman JA, Hurtz S, et al. Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy. Neurobiol Aging. 2016;39:82\u20139.","journal-title":"Neurobiol Aging"},{"key":"887_CR11","doi-asserted-by":"publisher","first-page":"241.e13","DOI":"10.1016\/j.neurobiolaging.2019.05.008","volume":"84","author":"XH Hou","year":"2019","unstructured":"Hou XH, Bi YL, Tan MS, Xu W, Li JQ, Shen XN, et al. Genome-wide association study identifies Alzheimer\u2019s risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels. Neurobiol Aging. 2019;84:241.e13-241.e20.","journal-title":"Neurobiol Aging"},{"key":"887_CR12","doi-asserted-by":"publisher","first-page":"eaau2291","DOI":"10.1126\/scitranslmed.aau2291","volume":"11","author":"Y Deming","year":"2019","unstructured":"Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci Transl Med. 2019;11:eaau2291.","journal-title":"Sci Transl Med"},{"key":"887_CR13","doi-asserted-by":"crossref","unstructured":"Lopes K de P, Snijders GJL, Humphrey J, Allan A, Sneeboer MAM, Navarro E, et al. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat Genet. 2022;54:4\u201317.","DOI":"10.1038\/s41588-021-00976-y"},{"key":"887_CR14","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41467-021-21823-y","volume":"12","author":"G Novikova","year":"2021","unstructured":"Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, et al. Integration of Alzheimer\u2019s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat Commun. 2021;12:1610.","journal-title":"Nat Commun"},{"key":"887_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 2015;10:633\u201344.","journal-title":"Cell Rep"},{"key":"887_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-021-02372-6","volume":"143","author":"AM Smith","year":"2022","unstructured":"Smith AM, Davey K, Tsartsalis S, Khozoie C, Fancy N, Tang SS, et al. Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u2019s pathology. Acta Neuropathol (Berl). 2022;143:75\u201391.","journal-title":"Acta Neuropathol (Berl)"},{"key":"887_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41593-024-01600-y","volume":"27","author":"R Mancuso","year":"2024","unstructured":"Mancuso R, Fattorelli N, Martinez-Muriana A, Davis E, Wolfs L, Van Den Daele J, et al. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer\u2019s disease-related amyloid-\u03b2 pathology. Nat Neurosci. 2024;27:886\u2013900.","journal-title":"Nat Neurosci"},{"issue":"1221","key":"887_CR18","first-page":"e15","volume":"36","author":"H Martiskainen","year":"2015","unstructured":"Martiskainen H, Viswanathan J, Nyk\u00e4nen NP, Kurki M, Helisalmi S, Natunen T, et al. Transcriptomics and mechanistic elucidation of Alzheimer\u2019s disease risk genes in the brain and in vitro models. Neurobiol Aging. 2015;36(1221):e15-28.","journal-title":"Neurobiol Aging"},{"key":"887_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neurobiolaging.2013.08.002","volume":"35","author":"P Proitsi","year":"2014","unstructured":"Proitsi P, Lee SH, Lunnon K, Keohane A, Powell J, Troakes C, et al. Alzheimer\u2019s disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. Neurobiol Aging. 2014;35:279\u201390.","journal-title":"Neurobiol Aging"},{"key":"887_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"887_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"887_CR22","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, et al. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16:848\u201350.","journal-title":"Nat Neurosci"},{"key":"887_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"887_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276-1290.e17.","journal-title":"Cell"},{"key":"887_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS, P\u00e1lovics R, Munson CN, Long C, Johansson PK, Yip O, et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature. 2024;628:154\u201361.","journal-title":"Nature"},{"key":"887_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s42255-022-00643-4","volume":"4","author":"L Leng","year":"2022","unstructured":"Leng L, Yuan Z, Pan R, Su X, Wang H, Xue J, et al. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to \u03b2-amyloid clearance. Nat Metab. 2022;4:1287\u2013305.","journal-title":"Nat Metab"},{"key":"887_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.arr.2016.07.002","volume":"32","author":"S Sol\u00e9-Dom\u00e8nech","year":"2016","unstructured":"Sol\u00e9-Dom\u00e8nech S, Cruz DL, Capetillo-Zarate E, Maxfield FR. The endocytic pathway in microglia during health, aging and Alzheimer\u2019s disease. Ageing Res Rev. 2016;32:89\u2013103.","journal-title":"Ageing Res Rev"},{"key":"887_CR28","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"887_CR29","doi-asserted-by":"crossref","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar Ab42 hotspots around plaques. Nat Commun. 2015.","DOI":"10.1038\/ncomms7176"},{"key":"887_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667\u201375.","journal-title":"J Exp Med"},{"key":"887_CR31","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystr\u00f6m S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358.","journal-title":"J Exp Med"},{"key":"887_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol. 2021;22:586\u201394.","journal-title":"Nat Immunol"},{"key":"887_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41586-022-05491-6","volume":"612","author":"P Yuan","year":"2022","unstructured":"Yuan P, Zhang M, Tong L, Morse TM, McDougal RA, Ding H, et al. PLD3 affects axonal spheroids and network defects in Alzheimer\u2019s disease. Nature. 2022;612:328\u201337.","journal-title":"Nature"},{"key":"887_CR34","doi-asserted-by":"publisher","first-page":"eaau7426","DOI":"10.1126\/sciadv.aau7426","volume":"5","author":"X Huang","year":"2019","unstructured":"Huang X, Feng Z, Jiang Y, Li J, Xiang Q, Guo S, et al. VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1\u03b2 in macrophages. Sci Adv. 2019;5:eaau7426.","journal-title":"Sci Adv"},{"key":"887_CR35","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/alz.13837","volume":"20","author":"H-Y Hu","year":"2024","unstructured":"Hu H-Y, Hu H, Jiang J, Bi Y-L, Sun Y, Ou Y-N, et al. Echocardiographic measures of the left heart and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact adults: The CABLE study. Alzheimers Dement J Alzheimers Assoc. 2024;20:3943\u201357.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"887_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"887_CR37","unstructured":"Ge YJ, Chen SD, Wu BS, Zhang YR, Wang J, He XY, et al. Genome-wide meta-analysis identifies ancestry-specific loci for Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc. 2024."},{"key":"887_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4:7.","journal-title":"GigaScience"},{"key":"887_CR39","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","volume":"273","author":"N Risch","year":"1996","unstructured":"Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516\u20137.","journal-title":"Science"},{"key":"887_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"887_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1471-2105-11-288","volume":"11","author":"R M\u00e4gi","year":"2010","unstructured":"M\u00e4gi R, Morris AP. GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics. 2010;11:288.","journal-title":"BMC Bioinformatics"},{"key":"887_CR42","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1038\/s41467-020-19730-9","volume":"11","author":"S Li","year":"2020","unstructured":"Li S, Yuan B, Cao J, Chen J, Chen J, Qiu J, et al. Docking sites inside Cas9 for adenine base editing diversification and RNA off-target elimination. Nat Commun. 2020;11:5827.","journal-title":"Nat Commun"},{"key":"887_CR43","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.cell.2022.04.003","volume":"185","author":"A Chen","year":"2022","unstructured":"Chen A, Liao S, Cheng M, Ma K, Wu L, Lai Y, et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell. 2022;185:1777-1792.e21.","journal-title":"Cell"},{"key":"887_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s12035-015-9669-1","volume":"54","author":"JQ Li","year":"2017","unstructured":"Li JQ, Wang HF, Zhu XC, Sun FR, Tan MS, Tan CC, et al. GWAS-linked loci and neuroimaging measures in alzheimer\u2019s disease. Mol Neurobiol. 2017;54:146\u201353.","journal-title":"Mol Neurobiol"},{"key":"887_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15:673\u201384.","journal-title":"Lancet Neurol"},{"key":"887_CR46","doi-asserted-by":"publisher","first-page":"a006221","DOI":"10.1101\/cshperspect.a006221","volume":"2","author":"K Blennow","year":"2012","unstructured":"Blennow K, Zetterberg H, Fagan AM. Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a006221.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"887_CR47","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.it.2021.07.002","volume":"42","author":"I Mattiola","year":"2021","unstructured":"Mattiola I, Mantovani A, Locati M. The tetraspan MS4A family in homeostasis, immunity, and disease. Trends Immunol. 2021;42:764\u201381.","journal-title":"Trends Immunol"},{"key":"887_CR48","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/nn.4160","volume":"18","author":"K Sharma","year":"2015","unstructured":"Sharma K, Schmitt S, Bergner CG, Tyanova S, Kannaiyan N, Manrique-Hoyos N, et al. Cell type- and brain region-resolved mouse brain proteome. Nat Neurosci. 2015;18:1819\u201331.","journal-title":"Nat Neurosci"},{"key":"887_CR49","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat Commun. 2015;6:6176.","journal-title":"Nat Commun"},{"key":"887_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-015-0139-9","volume":"7","author":"DG Walker","year":"2015","unstructured":"Walker DG, Lue L-F. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther. 2015;7:56.","journal-title":"Alzheimers Res Ther"},{"key":"887_CR51","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1523\/JNEUROSCI.23-06-02212.2003","volume":"23","author":"ME McLellan","year":"2003","unstructured":"McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J Neurosci Off J Soc Neurosci. 2003;23:2212\u20137.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"887_CR52","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3772","volume":"18","author":"IS Afonina","year":"2017","unstructured":"Afonina IS, Zhong Z, Karin M, Beyaert R. Limiting inflammation\u2014the negative regulation of NF-\u03baB and the NLRP3 inflammasome. Nat Immunol. 2017;18:861\u20139.","journal-title":"Nat Immunol"},{"key":"887_CR53","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9:857\u201365.","journal-title":"Nat Immunol"},{"key":"887_CR54","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"887_CR55","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41467-025-56124-1","volume":"16","author":"R Martins-Ferreira","year":"2025","unstructured":"Martins-Ferreira R, Calafell-Segura J, Leal B, Rodr\u00edguez-Ubreva J, Mart\u00ednez-Saez E, Mereu E, et al. The human microglia atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nat Commun. 2025;16:739.","journal-title":"Nat Commun"},{"key":"887_CR56","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"CC Liu","year":"2023","unstructured":"Liu CC, Wang N, Chen Y, Inoue Y, Shue F, Ren Y, et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat Immunol. 2023;24:1854\u201366.","journal-title":"Nat Immunol"},{"key":"887_CR57","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jalz.2012.11.012","volume":"9","author":"Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial Research Group","year":"2013","unstructured":"Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial Research Group. Results of a follow-up study to the randomized Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimers Dement J Alzheimers Assoc. 2013;9:714\u201323.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"887_CR58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(08)70090-5","volume":"7","author":"GK Wilcock","year":"2008","unstructured":"Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA, et al. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer\u2019s disease: a randomised phase II trial. Lancet Neurol. 2008;7:483\u201393.","journal-title":"Lancet Neurol"},{"key":"887_CR59","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1001\/jama.2009.1866","volume":"302","author":"RC Green","year":"2009","unstructured":"Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, et al. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 2009;302:2557\u201364.","journal-title":"JAMA"},{"key":"887_CR60","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MRP Elmore","year":"2014","unstructured":"Elmore MRP, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380\u201397.","journal-title":"Neuron"},{"key":"887_CR61","doi-asserted-by":"publisher","first-page":"e20210542","DOI":"10.1084\/jem.20210542","volume":"218","author":"M Gratuze","year":"2021","unstructured":"Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR, et al. Activated microglia mitigate A\u03b2-associated tau seeding and spreading. J Exp Med. 2021;218:e20210542.","journal-title":"J Exp Med"},{"key":"887_CR62","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun. 2019;10:3758.","journal-title":"Nat Commun"},{"key":"887_CR63","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MRP, Blurton-Jones M, et al. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain J Neurol. 2016;139:1265\u201381.","journal-title":"Brain J Neurol"},{"key":"887_CR64","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn.2432","volume":"12","author":"SA Grathwohl","year":"2009","unstructured":"Grathwohl SA, K\u00e4lin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, et al. Formation and maintenance of Alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia. Nat Neurosci. 2009;12:1361\u20133.","journal-title":"Nat Neurosci"},{"key":"887_CR65","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso A, Schetters STT, Sri S, Askew K, Mancuso R, Vargas-Caballero M, et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain J Neurol. 2016;139:891\u2013907.","journal-title":"Brain J Neurol"},{"key":"887_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:11.","journal-title":"Mol Neurodegener"},{"key":"887_CR67","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tins.2016.03.005","volume":"39","author":"V Chitu","year":"2016","unstructured":"Chitu V, Gokhan S, Nandi S, Mehler MF, Stanley ER. Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends Neurosci. 2016;39:378\u201393.","journal-title":"Trends Neurosci"},{"key":"887_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-017-0188-6","volume":"12","author":"R Zhao","year":"2017","unstructured":"Zhao R, Hu W, Tsai J, Li W, Gan W-B. Microglia limit the expansion of \u03b2-amyloid plaques in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2017;12:47.","journal-title":"Mol Neurodegener"},{"key":"887_CR69","doi-asserted-by":"publisher","first-page":"110961","DOI":"10.1016\/j.celrep.2022.110961","volume":"39","author":"S Kiani Shabestari","year":"2022","unstructured":"Kiani Shabestari S, Morabito S, Danhash EP, McQuade A, Sanchez JR, Miyoshi E, et al. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice. Cell Rep. 2022;39:110961.","journal-title":"Cell Rep"},{"key":"887_CR70","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1523\/JNEUROSCI.5077-10.2011","volume":"31","author":"A Wang","year":"2011","unstructured":"Wang A, Das P, Switzer RC, Golde TE, Jankowsky JL. Robust amyloid clearance in a mouse model of Alzheimer\u2019s disease provides novel insights into the mechanism of amyloid-beta immunotherapy. J Neurosci Off J Soc Neurosci. 2011;31:4124\u201336.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"887_CR71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1742-2094-11-48","volume":"11","author":"D Doens","year":"2014","unstructured":"Doens D, Fern\u00e1ndez PL. Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation. 2014;11:48.","journal-title":"J Neuroinflammation"},{"key":"887_CR72","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6:916\u20139.","journal-title":"Nat Med"},{"key":"887_CR73","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","volume":"23","author":"DM Wilcock","year":"2003","unstructured":"Wilcock DM, DiCarlo G, Henderson D, Jackson J, Clarke K, Ugen KE, et al. Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation. J Neurosci Off J Soc Neurosci. 2003;23:3745\u201351.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"887_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01273-8","volume":"8","author":"X Sun","year":"2023","unstructured":"Sun X, Yu X, Zhu J, Li L, Zhang L, Huang Y, et al. Fc effector of anti-A\u03b2 antibody induces synapse loss and cognitive deficits in Alzheimer\u2019s disease-like mouse model. Signal Transduct Target Ther. 2023;8:1\u201314.","journal-title":"Signal Transduct Target Ther"},{"key":"887_CR75","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/brain\/aws195","volume":"135","author":"P Fernandez-Vizarra","year":"2012","unstructured":"Fernandez-Vizarra P, Lopez-Franco O, Mallavia B, Higuera-Matas A, Lopez-Parra V, Ortiz-Mu\u00f1oz G, et al. Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice. Brain. 2012;135:2826\u201337.","journal-title":"Brain"},{"key":"887_CR76","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-012-0995-3","volume":"124","author":"JL Teeling","year":"2012","unstructured":"Teeling JL, Carare RO, Glennie MJ, Perry VH. Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction. Acta Neuropathol (Berl). 2012;124:479\u201390.","journal-title":"Acta Neuropathol (Berl)"},{"key":"887_CR77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-8-36","volume":"8","author":"CA Lemere","year":"2013","unstructured":"Lemere CA. Immunotherapy for Alzheimer\u2019s disease: hoops and hurdles. Mol Neurodegener. 2013;8:36.","journal-title":"Mol Neurodegener"},{"key":"887_CR78","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang L-L, Langfelder P, Li X, et al. Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models. Neuron. 2018;97:1032-1048.e5.","journal-title":"Neuron"},{"key":"887_CR79","doi-asserted-by":"publisher","first-page":"eabq0095","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang L, Fan X, Li L, Li X, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14:eabq0095.","journal-title":"Sci Transl Med"},{"key":"887_CR80","doi-asserted-by":"publisher","first-page":"e20200785","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217:e20200785.","journal-title":"J Exp Med"},{"key":"887_CR81","first-page":"416","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, et al. A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci. 2023;26:416\u201329.","journal-title":"Nat Neurosci"},{"key":"887_CR82","doi-asserted-by":"publisher","first-page":"e11227","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12:e11227.","journal-title":"EMBO Mol Med"},{"key":"887_CR83","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, et al. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflammation. 2020;17:238.","journal-title":"J Neuroinflammation"},{"key":"887_CR84","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","volume":"194","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Hern\u00e1ndez-Munain C, Cella M, Colonna M. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med. 2001;194:1111\u201322.","journal-title":"J Exp Med"},{"key":"887_CR85","doi-asserted-by":"publisher","first-page":"e20220654","DOI":"10.1084\/jem.20220654","volume":"220","author":"N Jain","year":"2023","unstructured":"Jain N, Lewis CA, Ulrich JD, Holtzman DM. Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading. J Exp Med. 2023;220:e20220654.","journal-title":"J Exp Med"},{"key":"887_CR86","doi-asserted-by":"publisher","first-page":"e2017742118","DOI":"10.1073\/pnas.2017742118","volume":"118","author":"DC Ellwanger","year":"2021","unstructured":"Ellwanger DC, Wang S, Brioschi S, Shao Z, Green L, Case R, et al. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2021;118:e2017742118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"887_CR87","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/s42255-022-00707-5","volume":"4","author":"Y Hu","year":"2022","unstructured":"Hu Y, Cao K, Wang F, Wu W, Mai W, Qiu L, et al. Dual roles of hexokinase 2 in shaping microglial function by gating glycolytic flux and mitochondrial activity. Nat Metab. 2022;4:1756\u201374.","journal-title":"Nat Metab"},{"key":"887_CR88","doi-asserted-by":"crossref","unstructured":"You S-F, Brase L, Filipello F, Iyer AK, Del-Aguila J, He J, et al. MS4A4A modifies the risk of alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state. Medrxiv Prepr Serv Health Sci. 2023;2023.2.6.23285545.","DOI":"10.1101\/2023.02.06.23285545"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00887-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00887-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00887-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:33:52Z","timestamp":1757450032000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00887-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00887-0","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CABLE study was carried out following the Declaration of Helsinki and the Qingdao Municipal Hospital's Institutional Ethics Committees approved the study's protocol. The current analyses were conducted under UK Biobank application number 19542. All of the experiments comply with the animal study protocol approved by the Fudan University. The consent for human body and organ donation (code number: 00303) was carefully signed by the donor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}